Q2 FY2026 · ended Jun 30, 2026 · Revenue $622.72M, +25.0% YoY · Filed Aug 10, 2026
RadNet, Inc. (RDNT) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $622.7 million and net income of $7.5 million. As of Jun 30, 2026 it held $726.3 million in cash and investments and $2.2 billion in total debt.
Revenue
$622.72M
+25.0% vs year-ago quarter
Net income
$7.53M
-47.9% vs year-ago quarter
Operating cash flow
$94.10M
-21.8% vs year-ago quarter
Free cash flow
—
EPS
$0.10
-47.4% vs year-ago quarter
Dividend per share
None
Shares outstanding
78.70M
+2.3% vs year-ago quarter
Net cash
$-1.46B
Q2 FY2026
Operating margin
3.1%
TTM
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RDNT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 790526
- Former names
- RadNet, Inc. (until Oct 26, 2026); PRIMEDEX HEALTH SYSTEMS INC (until Nov 21, 2006)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $622.7M | $575.6M | $547.7M | $522.9M | $498.2M |
| Operating income | $39.5M | -$23.9M | $27.8M | $27.4M | $30.9M |
| Net income | $7.5M | -$33.5M | -$597,000 | $5.4M | $14.5M |
| Diluted EPS | $0.10 | -$0.43 | -$0.01 | $0.07 | $0.19 |
| Operating cash flow | $94.1M | $79.0M | $84.2M | $52.8M | $120.3M |
| Total assets | $4.2B | $3.9B | $3.8B | $3.7B | $3.5B |
| Total liabilities | $2.8B | $2.5B | $2.4B | $2.4B | $2.3B |
| Stockholders' equity | $1.1B | $1.1B | $1.1B | $1.1B | $932.3M |
| Cash and investments | $726.3M | $455.3M | $767.2M | $804.7M | $833.2M |
| Total debt | $2.2B | $1.9B | $1.9B | $1.8B | $1.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 9, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
All 1000 RadNet, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.